SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study

Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown promise in reducing the risk of atrial fibrillation (AF). However, the results are controversial and the underlying metabolic mechanism remains uncl...

Source: Cardiovascular Diabetology - October 17, 2023 Category: Cardiology Authors: Jiang Li, Yuefeng Yu, Ying Sun, Bowei Yu, Xiao Tan, Bin Wang, Yingli Lu and Ningjian Wang Tags: Research Source Type: research